{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:16:09Z","timestamp":1786990569513,"version":"build-2736575974"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"DOI":"10.1093\/jac\/dkh510","type":"journal-article","created":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T01:13:40Z","timestamp":1101950020000},"page":"57-60","source":"Crossref","is-referenced-by-count":53,"title":["Fluoroquinolone consumption and resistance in haematology\u2013oncology patients: ecological analysis in two university hospitals 1999\u20132002"],"prefix":"10.1093","volume":"55","author":[{"given":"Winfried V.","family":"Kern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Steib-Bauert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"de With","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"von Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,1]]},"reference":[{"key":"key\n\t\t\t\t20171010175112_R1","doi-asserted-by":"crossref","unstructured":"Acar, J. F. & Goldstein, F. W. (1997). Trends in bacterial resistance to fluoroquinolones. Clinical Infectious Diseases24, Suppl. 1, S67\u2013S73.","DOI":"10.1093\/clinids\/24.Supplement_1.S67"},{"key":"key\n\t\t\t\t20171010175112_R2","doi-asserted-by":"crossref","unstructured":"Baquero, F. (1990). Resistance to quinolones in gram-negative microorganisms: mechanisms and prevention. European Urology17, Suppl. 1, 3\u201312.","DOI":"10.1159\/000464084"},{"key":"key\n\t\t\t\t20171010175112_R3","doi-asserted-by":"crossref","unstructured":"Fridkin, S. K., Hill, H. A., Volkova, N. V. et al. (2002). Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerging Infectious Diseases8, 697\u2013701.","DOI":"10.3201\/eid0807.010427"},{"key":"key\n\t\t\t\t20171010175112_R4","doi-asserted-by":"crossref","unstructured":"Aparicio, J. R., Such, J., Pascual, S. et al. (1999). Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences. Journal of Hepatology31, 277\u201383.","DOI":"10.1016\/S0168-8278(99)80225-6"},{"key":"key\n\t\t\t\t20171010175112_R5","doi-asserted-by":"crossref","unstructured":"Carratala, J., Fernandez-Sevilla, A., Tubau, F. et al. (1996). Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrobial Agents and Chemotherapy40, 503\u20135.","DOI":"10.1128\/AAC.40.2.503"},{"key":"key\n\t\t\t\t20171010175112_R6","doi-asserted-by":"crossref","unstructured":"Lautenbach, E., Fishman, N. O., Bilker, W. B. et al. (2002). Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Archives of Internal Medicine162, 2469\u201377.","DOI":"10.1001\/archinte.162.21.2469"},{"key":"key\n\t\t\t\t20171010175112_R7","doi-asserted-by":"crossref","unstructured":"Richard, P., Delangle, M. H., Merrien, D. et al. (1994). Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clinical Infectious Diseases19, 54\u20139.","DOI":"10.1093\/clinids\/19.1.54"},{"key":"key\n\t\t\t\t20171010175112_R8","doi-asserted-by":"crossref","unstructured":"De With, K., Schr\u00f6der, H., Meyer, E. et al. (2004). Antibiotikaanwendung in Deutschland im europ\u00e4ischen Vergleich. Deutsche Medizinische Wochenschrift129, 1987\u201392.","DOI":"10.1055\/s-2004-831838"},{"key":"key\n\t\t\t\t20171010175112_R9","unstructured":"De With, K., Schr\u00f6der, H., Steib-Bauert, M., et al. (2004). Antibiotic consumption in ambulatory care in Germany: a regional NUTS-I level analysis. In Program and Abstracts of the Fourteenth European Congress of Clinical Microbiology and Infectious Diseases, Prague, May 2004. Abstract P1187. Clinical Microbiology and Infection, 10, Suppl. 3, 326."},{"key":"key\n\t\t\t\t20171010175112_R10","doi-asserted-by":"crossref","unstructured":"Huovinen, P., Pulkkinen, L., Helin, H. L. et al. (1986). Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984. Antimicrobial Agents and Chemotherapy29, 73\u20136.","DOI":"10.1128\/AAC.29.1.73"},{"key":"key\n\t\t\t\t20171010175112_R11","doi-asserted-by":"crossref","unstructured":"Livermore, D. M., Stephens, P., Weinberg, J. et al. (2000). Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing. Journal of Antimicrobial Chemotherapy46, 411\u201322.","DOI":"10.1093\/jac\/46.3.411"},{"key":"key\n\t\t\t\t20171010175112_R12","doi-asserted-by":"crossref","unstructured":"Burman, W. J., Breese, P. E., Murray, B. E. et al. (2003). Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. American Journal of Medicine115, 358\u201364.","DOI":"10.1016\/S0002-9343(03)00372-3"},{"key":"key\n\t\t\t\t20171010175112_R13","doi-asserted-by":"crossref","unstructured":"Hartley, J. W. & Oppenheim, B. A. (1989). In vitro induction of ciprofloxacin resistance in coagulase-negative staphylococci. Infection17, 247\u20138.","DOI":"10.1007\/BF01639530"},{"key":"key\n\t\t\t\t20171010175112_R14","doi-asserted-by":"crossref","unstructured":"Monsen, T., Ronnmark, M., Olofsson, C. et al. (1999). Antibiotic susceptibility of staphylococci isolated in blood cultures in relation to antibiotic consumption in hospital wards. Scandinavian Journal of Infectious Diseases31, 399\u2013404.","DOI":"10.1080\/00365549950163860"},{"key":"key\n\t\t\t\t20171010175112_R15","unstructured":"Utili, R., Tripodi, M. F., Rosario, P. et al. (1996). Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin. New Microbiology19, 309\u201314."},{"key":"key\n\t\t\t\t20171010175112_R16","doi-asserted-by":"crossref","unstructured":"Hoiby, N., Jarlov, J. O., Kemp, M. et al. (1997). Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet349, 167\u20139.","DOI":"10.1016\/S0140-6736(96)09229-X"},{"key":"key\n\t\t\t\t20171010175112_R17","doi-asserted-by":"crossref","unstructured":"Gustafsson, I., Cars, O. & Andersson, D. I. (2003). Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. Journal of Antimicrobial Chemotherapy52, 258\u201363.","DOI":"10.1093\/jac\/dkg331"},{"key":"key\n\t\t\t\t20171010175112_R18","doi-asserted-by":"crossref","unstructured":"Weber, S. G., Gold, H. S., Hooper, D. C. et al. (2003). Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerging Infectious Diseases9, 1415\u201322.","DOI":"10.3201\/eid0911.030284"},{"key":"key\n\t\t\t\t20171010175112_R19","doi-asserted-by":"crossref","unstructured":"Jarlov, J. O. & Hoiby, N. (1998). Coagulase-negative staphylococci in a major Danish university hospital: diversity in antibiotic susceptibility between wards. APMIS106, 411\u20136.","DOI":"10.1111\/j.1699-0463.1998.tb01365.x"},{"key":"key\n\t\t\t\t20171010175112_R20","doi-asserted-by":"crossref","unstructured":"Mulder, J. G., Kosterink, J. G. & Degener, J. E. (1997). The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures. Journal of Antimicrobial Chemotherapy40, 701\u20136.","DOI":"10.1093\/jac\/40.5.701"},{"key":"key\n\t\t\t\t20171010175112_R21","doi-asserted-by":"crossref","unstructured":"Hedin, G. & Hambraeus, A. (1991). Multiply antibiotic-resistant Staphylococcus epidermidis in patients, staff and environment\u2014a one-week survey in a bone marrow transplant unit. Journal of Hospital Infection17, 95\u2013106.","DOI":"10.1016\/0195-6701(91)90173-6"},{"key":"key\n\t\t\t\t20171010175112_R22","doi-asserted-by":"crossref","unstructured":"Kotilainen, P., Nikoskelainen, J. & Huovinen, P. (1990). Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. Journal of Infectious Diseases161, 41\u20134.","DOI":"10.1093\/infdis\/161.1.41"},{"key":"key\n\t\t\t\t20171010175112_R23","doi-asserted-by":"crossref","unstructured":"Bager, F. (2000). DANMAP: monitoring antimicrobial resistance in Denmark. International Journal of Antimicrobial Agents14, 271\u20134.","DOI":"10.1016\/S0924-8579(00)00135-7"},{"key":"key\n\t\t\t\t20171010175112_R24","doi-asserted-by":"crossref","unstructured":"Bellomo, R., Bersten, A. D., Boots, R. J. et al. (1998). The use of antimicrobials in ten Australian and New Zealand intensive care units. The Australian and New Zealand Intensive Care Multicentre Studies Group Investigators. Anaesthesia and Intensive Care26, 648\u201353.","DOI":"10.1177\/0310057X9802600606"},{"key":"key\n\t\t\t\t20171010175112_R25","doi-asserted-by":"crossref","unstructured":"Meyer, E., Jonas, D., Schwab, F. et al. (2003). Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection31, 208\u201315.","DOI":"10.1007\/s15010-003-3201-7"},{"key":"key\n\t\t\t\t20171010175112_R26","doi-asserted-by":"crossref","unstructured":"Fridkin, S. K., Steward, C. D., Edwards, J. R. et al. (1999). Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clinical Infectious Diseases29, 245\u201352.","DOI":"10.1086\/520193"},{"key":"key\n\t\t\t\t20171010175112_R27","doi-asserted-by":"crossref","unstructured":"Gomez, L., Garau, J., Estrada, C. et al. (2003). Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. Cancer97, 419\u201324.","DOI":"10.1002\/cncr.11044"},{"key":"key\n\t\t\t\t20171010175112_R28","doi-asserted-by":"crossref","unstructured":"Martino, R., Subira, M., Altes, A. et al. (1998). Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case\u2013control study of the effect on infectious morbidity. Acta Haematologica99, 206\u201311.","DOI":"10.1159\/000040840"},{"key":"key\n\t\t\t\t20171010175112_R29","unstructured":"Delarive, P., Baumgartner, J. D., Glauser, M. P. et al. (2000). Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies. Schweizerische Medizinische Wochenschrift130, 1837\u201344."}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/1\/57\/2333248\/dkh510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T12:49:20Z","timestamp":1586004560000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/1\/57\/777126\/Fluoroquinolone-consumption-and-resistance-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,1]]},"published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkh510","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,1]]},"published":{"date-parts":[[2005,1,1]]}}}